These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35887157)

  • 1. In Silico Study of Allosteric Communication Networks in GPCR Signaling Bias.
    Morales-Pastor A; Nerín-Fonz F; Aranda-García D; Dieguez-Eceolaza M; Medel-Lacruz B; Torrens-Fontanals M; Peralta-García A; Selent J
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric communication pipelines in G-protein-coupled receptors.
    Vaidehi N; Bhattacharya S
    Curr Opin Pharmacol; 2016 Oct; 30():76-83. PubMed ID: 27497048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
    Slosky LM; Caron MG; Barak LS
    Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery.
    Zhang M; Lan X; Li X; Lu S
    Drug Discov Today; 2023 Dec; 28(12):103803. PubMed ID: 37852356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.
    Bartuzi D; Kaczor AA; Matosiuk D
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28714871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Divergent Binding Pocket Closure Drive Ligand Bias for Class A GPCRs?
    Bermudez M; Bock A
    Trends Pharmacol Sci; 2019 Apr; 40(4):236-239. PubMed ID: 30852058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural perspectives on allosteric modulation of GPCRs.
    Langmead CJ; Christopoulos A
    Curr Opin Cell Biol; 2014 Apr; 27():94-101. PubMed ID: 24680434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric communication regulates ligand-specific GPCR activity.
    Ma N; Nivedha AK; Vaidehi N
    FEBS J; 2021 Apr; 288(8):2502-2512. PubMed ID: 33738925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.
    White KL; Eddy MT; Gao ZG; Han GW; Lian T; Deary A; Patel N; Jacobson KA; Katritch V; Stevens RC
    Structure; 2018 Feb; 26(2):259-269.e5. PubMed ID: 29395784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent updates on GPCR biased agonism.
    Pupo AS; Duarte DA; Lima V; Teixeira LB; Parreiras-E-Silva LT; Costa-Neto CM
    Pharmacol Res; 2016 Oct; 112():49-57. PubMed ID: 26836887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCR Allosteric Modulator Discovery.
    Wu Y; Tong J; Ding K; Zhou Q; Zhao S
    Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Trends in GPCR Allostery.
    Singh KD; Karnik SS
    J Membr Biol; 2021 Jun; 254(3):293-300. PubMed ID: 33471142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.